The Evidence Base of Vildagliptin for T2DM Patient During Ramadan

Agung Pranoto (2017) The Evidence Base of Vildagliptin for T2DM Patient During Ramadan. In: Proceeding The Quadruple Joint Symposium-2017A. Pusat Diabetes Dan Nutrisi Departemen-SMF Penyakit Dalam Fakultas Kedokteran Universitas Airlangga, Surabaya, pp. 81-88. ISBN 978-602-71520-8-3

[img] Text (Artikel)
The Evidence Base of Vildagliptin for T2DM Patient During Ramadan_compressed.pdf

Download (2MB)
[img] Text (Similarity)
The Evidence Base of Vildagliptin for T2DM Patient During Ramadan.pdf

Download (2MB)
[img] Text (Peer Review)
peer.pdf

Download (1MB)

Abstract

Dipeptidyl peptidase-4 (DPP-4) inhibitors merupakan obat golongan baru (vildagliptin sitagliptin, saxagliptin, linagliptin, alogliptin), obat yang meningkatkan kontrol glikemik dengan memperbaiki fungsi dari hormone incretin, sehingga pada pengelolaan Diabetes Mellitus (DM), diberi nama dengan "incretin based therapy". Dalam fisiologi normal, usus memberikan respon terhadap asupan makanan dengan melepaskan hormone incretin misal GLP-1 (glucagon like peptide-1) dan GIP (gastric inhibitory polypeptide), yang berefek meningkatkan biosintesis dan sekresi insulin, dan memperlambat waktu pengosongan lambung.

Item Type: Book Section
Uncontrolled Keywords: Vildagliptin, Patient During Ramadan, T2DM
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine > RC31-1245 Internal medicine
Divisions: 01. Fakultas Kedokteran > Ilmu Penyakit Dalam
Creators:
CreatorsNIM/NIDN
Agung PranotoNIDN0004015605
Depositing User: hanif kurniawan
Date Deposited: 02 Oct 2019 08:15
Last Modified: 27 Dec 2019 09:47
URI: http://repository.unair.ac.id/id/eprint/86383
Sosial Share:

Actions (login required)

View Item View Item